SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-765907
Filing Date
2016-11-10
Accepted
2016-11-10 16:14:03
Documents
68
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d255357d10q.htm 10-Q 704057
2 EX-10.1 d255357dex101.htm EX-10.1 363539
3 EX-31.1 d255357dex311.htm EX-31.1 5394
4 EX-31.2 d255357dex312.htm EX-31.2 5371
5 EX-32.1 d255357dex321.htm EX-32.1 3425
6 EX-32.2 d255357dex322.htm EX-32.2 3412
  Complete submission text file 0001193125-16-765907.txt   4462867

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dnai-20160930.xml EX-101.INS 654600
8 XBRL TAXONOMY EXTENSION SCHEMA dnai-20160930.xsd EX-101.SCH 50229
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dnai-20160930_cal.xml EX-101.CAL 56290
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dnai-20160930_def.xml EX-101.DEF 215166
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dnai-20160930_lab.xml EX-101.LAB 431207
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dnai-20160930_pre.xml EX-101.PRE 308405
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
ProNAi Therapeutics Inc (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 161988191
SIC: 2834 Pharmaceutical Preparations